Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Lehman

Showing results (401-410 of 425) with videos related to

Pageof 43
Sort By:
JTO Clinical and Research Reports|April 27, 2026
Durvalumab Plus Chemotherapy in Patients With <i>EGFR</i>-Mutated Advanced NSCLC Whose Disease Progressed on First-Line Osimertinib: ORCHARDByoung Chul Cho, Makoto Nishio, Myung-Ju Ahn, et al.
American Journal of Human Genetics|February 18, 2014
Mitochondrial carbonic anhydrase VA deficiency resulting from CA5A alterations presents with hyperammonemia in early childhoodClara D van Karnebeek, William S Sly, Colin J Ross, et al.
Developmental Cognitive Neuroscience|February 25, 2025
Longitudinal analysis of the ABCD® studySamuel W Hawes, Andrew K Littlefield, Daniel A Lopez, et al.
Blood|July 27, 2013
Ibrutinib is an irreversible molecular inhibitor of ITK driving a Th1-selective pressure in T lymphocytesJason A Dubovsky, Kyle A Beckwith, Gayathri Natarajan, et al.
JCI Insight|December 21, 2018
Sialic acid catabolism by N-acetylneuraminate pyruvate lyase is essential for muscle functionXiao-Yan Wen, Maja Tarailo-Graovac, Koroboshka Brand-Arzamendi, et al.
BMC Proceedings|December 17, 2016
Omics-squared: human genomic, transcriptomic and phenotypic data for genetic analysis workshop 19John Blangero, Tanya M Teslovich, Xueling Sim, et al.
Lipids in Health and Disease|September 22, 2021
APOC3 genetic variation, serum triglycerides, and risk of coronary artery disease in Asian Indians, Europeans, and other ethnic groupsShiwali Goyal, Yosuke Tanigawa, Weihua Zhang, et al.
Nature Communications|January 7, 2023
Dysregulation of PRMT5 in chronic lymphocytic leukemia promotes progression with high risk of Richter's transformationZachary A Hing, Janek S Walker, Ethan C Whipp, et al.
Cancer Discovery|February 2, 2018
BRD4 Profiling Identifies Critical Chronic Lymphocytic Leukemia Oncogenic Circuits and Reveals Sensitivity to PLX51107, a Novel Structurally Distinct BET InhibitorHatice Gulcin Ozer, Dalia El-Gamal, Ben Powell, et al.
Zoonoses and Public Health|March 29, 2014
A large-scale, rapid public health response to rabies in an organ recipient and the previously undiagnosed organ donorR M Wallace, D Stanek, S Griese, et al.
Pageof 43

Showing results (401-410 of 425) with videos related to

Sort By:
Pageof 43
JTO Clinical and Research Reports|April 27, 2026
Durvalumab Plus Chemotherapy in Patients With <i>EGFR</i>-Mutated Advanced NSCLC Whose Disease Progressed on First-Line Osimertinib: ORCHARDByoung Chul Cho, Makoto Nishio, Myung-Ju Ahn, et al.
American Journal of Human Genetics|February 18, 2014
Mitochondrial carbonic anhydrase VA deficiency resulting from CA5A alterations presents with hyperammonemia in early childhoodClara D van Karnebeek, William S Sly, Colin J Ross, et al.
Developmental Cognitive Neuroscience|February 25, 2025
Longitudinal analysis of the ABCD® studySamuel W Hawes, Andrew K Littlefield, Daniel A Lopez, et al.
Blood|July 27, 2013
Ibrutinib is an irreversible molecular inhibitor of ITK driving a Th1-selective pressure in T lymphocytesJason A Dubovsky, Kyle A Beckwith, Gayathri Natarajan, et al.
JCI Insight|December 21, 2018
Sialic acid catabolism by N-acetylneuraminate pyruvate lyase is essential for muscle functionXiao-Yan Wen, Maja Tarailo-Graovac, Koroboshka Brand-Arzamendi, et al.
BMC Proceedings|December 17, 2016
Omics-squared: human genomic, transcriptomic and phenotypic data for genetic analysis workshop 19John Blangero, Tanya M Teslovich, Xueling Sim, et al.
Lipids in Health and Disease|September 22, 2021
APOC3 genetic variation, serum triglycerides, and risk of coronary artery disease in Asian Indians, Europeans, and other ethnic groupsShiwali Goyal, Yosuke Tanigawa, Weihua Zhang, et al.
Nature Communications|January 7, 2023
Dysregulation of PRMT5 in chronic lymphocytic leukemia promotes progression with high risk of Richter's transformationZachary A Hing, Janek S Walker, Ethan C Whipp, et al.
Cancer Discovery|February 2, 2018
BRD4 Profiling Identifies Critical Chronic Lymphocytic Leukemia Oncogenic Circuits and Reveals Sensitivity to PLX51107, a Novel Structurally Distinct BET InhibitorHatice Gulcin Ozer, Dalia El-Gamal, Ben Powell, et al.
Zoonoses and Public Health|March 29, 2014
A large-scale, rapid public health response to rabies in an organ recipient and the previously undiagnosed organ donorR M Wallace, D Stanek, S Griese, et al.
Pageof 43